期刊文献+

mTOR及其抑制剂抗肿瘤临床研究进展 被引量:2

下载PDF
导出
摘要 1 mTOR的结构与功能mTOR是一种大分子蛋白质,分子量为289kDa,由2459个氨基酸分子组成,如图1所示,mTOR蛋白激酶域位于分子的C端。
出处 《河北医学》 CAS 2011年第5期694-697,共4页 Hebei Medicine
  • 相关文献

参考文献18

  • 1Nissim H,Nahum S.Upstream and downstream of mTOR[J].Genes Dev.2004,18(16):1926-1945. 被引量:1
  • 2Choi J,Chen J,Schreiber SL,et al.Structure of the FKBP12?rapamycin complex interacting with the binding domain of human FRAP[J].Science.1996,273:239-342. 被引量:1
  • 3Jacinto E,Loewith R,Schmidt A,et al.Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive[J].Nat Cell Biol,2004,6:1122-1128. 被引量:1
  • 4Andrew C,Hsieh,Maria Costa,et al.Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E[J].Cancer Cell,2010,17(3):249-261. 被引量:1
  • 5Dufner A,Thomas J.Ribosomal S6 kinase signaling and the control of translation[J].Exp Cell Res,1999,253:100-109. 被引量:1
  • 6Vezina C,Kudelski A,Sehgal SN.Rapamycin (AY?22,989),a new antifungal antibiotic.I.Taxonomy of the producing streptomycete and isolation of the active principle[J].Antibiot (Tokyo),1975,28:721-726. 被引量:1
  • 7Cejka D,Preusser M,Fuereder T,et al.mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo[J].Anticancer Res,2008,28(6A):3801-3808. 被引量:1
  • 8Hosono Y,Osada S,Nawa M,et al.Combination therapy of 5-fluorouracil with rapamycin for hormone receptor-negative human breast cancer[J].Anticancer Res,2010,30(7):2625-2630. 被引量:1
  • 9Perl AE,Kasner MT,Tsai DE,et al.A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia[J].Clin Cancer Res,2009,15(21):6732-6739. 被引量:1
  • 10Rizell M,Andersson M,Cahlin C,et al.Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer[J].Int Clin Oncol,2008,13(1):66-70. 被引量:1

同被引文献34

  • 1Noh WC, Kim YH, Kim MS, et al. Activation of the mTOR signaling pathway in breast cancer and its correlation with the ctinicopatholngic variables[J]. Breast Cancer Res Treat ,2008,110(3):477-483. 被引量:1
  • 2Martelli AM, Evangelisti C, Chiarini F, et al. The phosphatidyli- nositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients[J]. Oncotarget, 2010,1 (2) : 89-103. 被引量:1
  • 3Maehama T,Dixon JE. The tumor suppressor,PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinosi- tol 3,4,5-trisphosphate[J]. J Biol Chem, 1998,273(22) : 13375- 13378. 被引量:1
  • 4Steelman LS,Navolanic PM,Sokolosky ML,et al. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to roTOR inhibitors[J]. Oneogene,2008,27(29) :4086-4095. 被引量:1
  • 5Bae-Jump VL,Zhou C,Boggess JF,et al. Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment[J]. Gynecol On- col,2010,119(3) :579-585. 被引量:1
  • 6Fang Y,Vilella-Bach M,Bachmann R,et al.Phosphatidic acid mediated mitogenie aactivation of mTOR signaling[J].Science,2001,294(5548):1942-1945. 被引量:1
  • 7贾海泉,蔺会云,徐元基,等.MAG-1对肿瘤细胞迁移、黏附和侵袭能力的影响及其作用机制的研究[C].第五届中国肿瘤学术大会暨第七届海峡两岸肿瘤学术会议、国际肿瘤细胞与基因治疗学术会议、第二届中日肿瘤介入治疗学术会议论文集,2008:190-205. 被引量:1
  • 8Wang Y,Jia H,Lin H,et al.Metastasis-associated gene,MAG-1 improves tumor microenvironmental adaptation and potentiates tumor metastasis[J].J Cell Mol Med,2012,16(12):3037-3051. 被引量:1
  • 9Joseph Avruch,Xiaomeng Long,Yenshou Lin,et al.Activation of mTORC1 in two steps:Rheb-GTP activation of catalytic function and increased binding of substrates to raptor[J].Biochem Society Transactions,2009,37(1):223-226. 被引量:1
  • 10Ryan C Russell,Chong Fang,Kun-Liang Guan.An emerging role for TOR signaling in mammalian tissue and stem cell physiology[J].Development,2011,138(16):3343-3356. 被引量:1

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部